- Home
- PPL vs DXCM Comparison
PPL vs DXCM Comparison
Compare PPL & DXCM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Company Overview
Basic Information| Metric | PPL | DXCM |
|---|---|---|
| Founded | 1920 | 1999 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Electric Utilities: Central | Medical/Dental Instruments |
| Sector | Utilities | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 24.8B | 25.9B |
| IPO Year | N/A | 2005 |
Fundamental Metrics
Financial Performance| Metric | PPL | DXCM |
|---|---|---|
| Price | $34.79 | $67.02 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 8 | 21 |
| Target Price | $40.75 | ★ $86.86 |
| AVG Volume (30 Days) | ★ 7.2M | 5.3M |
| Earning Date | 02-12-2026 | 02-12-2026 |
| Dividend Yield | ★ 3.14% | N/A |
| EPS Growth | ★ 32.44 | 7.75 |
| EPS | 1.47 | ★ 1.80 |
| Revenue | ★ $8,979,000,000.00 | $4,515,900,000.00 |
| Revenue This Year | $7.55 | $17.41 |
| Revenue Next Year | $5.11 | $12.78 |
| P/E Ratio | ★ $23.59 | $37.53 |
| Revenue Growth | 8.42 | ★ 14.21 |
| 52 Week Low | $31.22 | $54.11 |
| 52 Week High | $38.27 | $93.25 |
Technical Indicators
Market Signals| Indicator | PPL | DXCM |
|---|---|---|
| Relative Strength Index (RSI) | 47.78 | 58.00 |
| Support Level | $34.08 | $65.56 |
| Resistance Level | $34.89 | $67.95 |
| Average True Range (ATR) | 0.49 | 1.91 |
| MACD | 0.14 | 0.11 |
| Stochastic Oscillator | 92.53 | 51.30 |
Price Performance
Historical ComparisonAbout PPL PPL Corporation
PPL is a holding company of regulated utilities in Pennsylvania, Kentucky, and Rhode Island. The Pennsylvania regulated delivery and transmission segment distributes electricity to customers in central and eastern Pennsylvania. In Kentucky, LG&E and KU are involved in regulated electricity generation, transmission, and distribution. LG&E also provides regulated natural gas distribution. Rhode Island Energy operates electric and gas utilities in the state.
About DXCM DexCom Inc.
DexCom designs and commercializes continuous glucose monitoring systems for diabetic patients. CGM systems serve as an alternative to the traditional blood glucose meter process, and the company is evolving its CGM systems to provide integration with insulin pumps from Insulet and Tandem for automatic insulin delivery.